SOPHARMA (SPH): Sopharma monthly May 2014 - raport 59
Raport ESPI
UNI - EN REPORT No59/2014
Sopharma AD (the “Company”) notifies that for May 2014 the Company recorded a decrease of sales revenues of 14% compared to the same period of 2013, including same level of domestic sales and 18% decrease of export sales. The decline in export sales is mainly due to the stagnation of the Ukrainian market and the difficult access to the eastern regions of Ukraine.
During the past five months Sopharma AD recorded a decrease of sales revenues of 2%, including 2% increase of domestic sales and 3% decrease of export sales compared to 2013.
